Who we are
BioDar is a pioneering company at the forefront of health research and innovation, leveraging over 60 years of collective experience from its founders. Our multidisciplinary team is dedicated to advancing healthcare through cutting-edge research and comprehensive innovation management. We specialize in health research and innovation, with a focus on developing groundbreaking health technologies such as oral vaccines. BioDar offers a wide range of services designed to support various aspects of the biotech and healthcare industries.
Meet the Founding Team
BioDar was born from a shared vision between three university friends who met during their undergraduate studies. After graduation, each pursued separate but complementary paths in the biotech and healthcare industries. Years later, their paths crossed again, and they decided to combine their extensive knowledge and expertise to create BioDar. With over 60 years of collective experience, they are dedicated to advancing healthcare through cutting-edge research and comprehensive innovation management. Together, they lead BioDar in pioneering health research and developing groundbreaking technologies, such as oral vaccines, to support and transform the biotech and healthcare industries
-
Founder and Managing PartnerSherif Abouelhadid is a deputy director at the Antimicrobial Resistance Centre, London School of Hygiene & Tropical Medicine, United Kingdom. Over the last 15 years, he contributed to developing several vaccines against the World Health Organisation Bacterial Pathogen Priority List. He published seminal work in vaccine development and infection microbiology and holds a patent in vaccine technology. Sherif has extensive experience in vaccine development in industry and academia, having worked at a leading vaccine company in Africa and a leading public health institute in the UK. Sherif is also the co-founder of the Per-Ankh Foundation for Science & Technology, a deeptech focused foundation leveraging science innovation to provide effective solutions against socioeconomic and health burden in the Middle East and North Africa.
-
CoFounderAmr Radwan is a pharmacologist with industrial & fund management expertise. He is also an adjunct professor of practice in Management of Technology at Nile University. Amr He holds a PhD in Pharmacology & Toxicology, an MBA, and diplomas in investment management and intellectual property rights. Throughout his career, Amr has held senior R&D positions and has served as a technology strategist and innovation management practitioner at several international agencies and consulting firms. He participated in over 30 competitive EU and UN-funded research and innovation projects with total value exceeding $100m. He co-developed several research and innovation funding programs in the Euro-Med region. He published in health domains, Science Policy, innovation economics, & R&D management. He has contributed to Egypt STI 2030 strategy & Egypt’s sustainable development vision 2030 (knowledge pillar), Egypt’s National Health research priorities, EU-Africa Strategy for personalized medicine, Euro-Med quintuple innovation helix roadmap, among several technological roadmaps & strategies. Amr served as the supervisor of research and innovation at the Academy of Scientific Research and Technology in Egypt where he also developed several national research & innovation programs including the national biomedical and health research program (PRISM). He has also been a member of several national and international research programs and councils, including the Africa Funding Hub, the Medical Research Council in Egypt, the European Joint Programming Initiative on Antimicrobial Resistance, and the global coalition of research funders in infectious diseases (GloPID-R).
